These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 16940332

  • 1. A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release.
    Brown MG, King CA, Sherren C, Marshall JS, Anderson R.
    J Leukoc Biol; 2006 Dec; 80(6):1242-50. PubMed ID: 16940332
    [Abstract] [Full Text] [Related]

  • 2. Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells.
    Brown MG, Huang YY, Marshall JS, King CA, Hoskin DW, Anderson R.
    J Leukoc Biol; 2009 Jan; 85(1):71-80. PubMed ID: 18809735
    [Abstract] [Full Text] [Related]

  • 3. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.
    Littaua R, Kurane I, Ennis FA.
    J Immunol; 1990 Apr 15; 144(8):3183-6. PubMed ID: 2139079
    [Abstract] [Full Text] [Related]

  • 4. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors.
    Mady BJ, Erbe DV, Kurane I, Fanger MW, Ennis FA.
    J Immunol; 1991 Nov 01; 147(9):3139-44. PubMed ID: 1680925
    [Abstract] [Full Text] [Related]

  • 5. Autophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells.
    Fang YT, Wan SW, Lu YT, Yao JH, Lin CF, Hsu LJ, Brown MG, Marshall JS, Anderson R, Lin YS.
    PLoS One; 2014 Nov 01; 9(10):e110655. PubMed ID: 25329914
    [Abstract] [Full Text] [Related]

  • 6. Dengue virus selectively induces human mast cell chemokine production.
    King CA, Anderson R, Marshall JS.
    J Virol; 2002 Aug 01; 76(16):8408-19. PubMed ID: 12134044
    [Abstract] [Full Text] [Related]

  • 7. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
    Guy B, Chanthavanich P, Gimenez S, Sirivichayakul C, Sabchareon A, Begue S, Yoksan S, Luxemburger C, Lang J.
    Vaccine; 2004 Sep 09; 22(27-28):3563-74. PubMed ID: 15315835
    [Abstract] [Full Text] [Related]

  • 8. Zika Virus Replication in a Mast Cell Model is Augmented by Dengue Virus Antibody-Dependent Enhancement and Features a Selective Immune Mediator Secretory Profile.
    Coish JM, Crozier RWE, Schieffelin JS, Coorssen JR, Hunter FF, MacNeil AJ.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0177222. PubMed ID: 35862953
    [Abstract] [Full Text] [Related]

  • 9. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors.
    Li M, Zhao L, Zhang C, Wang X, Hong W, Sun J, Liu R, Yu L, Wang J, Zhang F, Jin X.
    PLoS One; 2018 Aug 31; 13(7):e0200478. PubMed ID: 30044839
    [Abstract] [Full Text] [Related]

  • 10. Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA.
    Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I.
    J Virol Methods; 2010 Feb 31; 163(2):205-9. PubMed ID: 19781573
    [Abstract] [Full Text] [Related]

  • 11. RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection.
    Brown MG, McAlpine SM, Huang YY, Haidl ID, Al-Afif A, Marshall JS, Anderson R.
    PLoS One; 2012 Feb 31; 7(3):e34055. PubMed ID: 22479521
    [Abstract] [Full Text] [Related]

  • 12. Antibody-mediated enhancement of infection by dengue virus of the P815 murine mastocytoma cell line.
    Legrand LF, Hotta H, Hotta S, Homma M.
    Biken J; 1986 Jun 31; 29(2):51-5. PubMed ID: 3101662
    [Abstract] [Full Text] [Related]

  • 13. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection.
    Moi ML, Lim CK, Takasaki T, Kurane I.
    J Gen Virol; 2010 Jan 31; 91(Pt 1):103-11. PubMed ID: 19776239
    [Abstract] [Full Text] [Related]

  • 14. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells.
    Kou Z, Quinn M, Chen H, Rodrigo WW, Rose RC, Schlesinger JJ, Jin X.
    J Med Virol; 2008 Jan 31; 80(1):134-46. PubMed ID: 18041019
    [Abstract] [Full Text] [Related]

  • 15. Virus stimulation of human mast cells results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 ligands.
    McAlpine SM, Issekutz TB, Marshall JS.
    FASEB J; 2012 Mar 31; 26(3):1280-9. PubMed ID: 22125314
    [Abstract] [Full Text] [Related]

  • 16. A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells.
    Konishi E, Tabuchi Y, Yamanaka A.
    J Virol Methods; 2010 Feb 31; 163(2):360-7. PubMed ID: 19883692
    [Abstract] [Full Text] [Related]

  • 17. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line.
    King CA, Marshall JS, Alshurafa H, Anderson R.
    J Virol; 2000 Aug 31; 74(15):7146-50. PubMed ID: 10888655
    [Abstract] [Full Text] [Related]

  • 18. Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement.
    Sun P, Bauza K, Pal S, Liang Z, Wu SJ, Beckett C, Burgess T, Porter K.
    Virology; 2011 Dec 20; 421(2):245-52. PubMed ID: 22033262
    [Abstract] [Full Text] [Related]

  • 19. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus.
    Ito M, Mukai RZ, Takasaki T, Kotaki A, Kurane I.
    Arch Virol; 2010 Oct 20; 155(10):1617-24. PubMed ID: 20644969
    [Abstract] [Full Text] [Related]

  • 20. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
    Ramadhany R, Hirai I, Sasaki T, Ono K, Ramasoota P, Ikuta K, Kurosu T.
    Antiviral Res; 2015 Dec 20; 124():61-8. PubMed ID: 26522769
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.